Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
JBM (Healthcare) Ltd. ( (HK:2161) ) has shared an announcement.
JBM (Healthcare) Limited has announced the updated list of its board of directors and their respective roles within the company, effective from October 2, 2025. This update reflects the company’s ongoing commitment to strong governance and strategic leadership, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:2161) stock is a Buy with a HK$3.50 price target. To see the full list of analyst forecasts on JBM (Healthcare) Ltd. stock, see the HK:2161 Stock Forecast page.
More about JBM (Healthcare) Ltd.
Average Trading Volume: 1,081,044
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.41B
For detailed information about 2161 stock, go to TipRanks’ Stock Analysis page.